Krista F. Huybrechts, MS, PhD | Psychiatrist.com

Atomoxetine and Prevalence of Major Congenital Malformations

Original Research

Atomoxetine and Prevalence of Major Congenital Malformations

January 16, 2023

Little is known about the safety of atomoxetine, a non-stimulant treatment for attention-deficit/hyperactivity disorder. This study assessed the prevalence of major congenital malformations after first-trimester exposure to atomoxetine.

Gabriella Bröms, Sonia Hernández-Díaz, Krista F. Huybrechts, et al

Original Research

Mood Stabilizers and Placenta-Mediated Complications

June 18, 2019

Women who take mood stabilizers have a greater risk of placenta-mediated pregnancy complications. But are the mood stabilizers themselves responsible for this higher risk? This study explores that question.

Jacqueline M. Cohen, Krista F. Huybrechts, Elisabetta Patorno, et al

Perspectives on the New FDA Pregnancy and Lactation Labeling Rule

Academic Highlights

Perspectives on the New FDA Pregnancy and Lactation Labeling Rule

July 17, 2018

Pregnancy labeling of prescription medications in the US is in the midst of a major transformation. Are you aware of the changes? Read this summary of a recent conference...

Marlene P. Freeman, Tiffany Farchione, Lynn Yao, et al